High-Grade Astrocytoma with Piloid Features (HGAP): When Persistent Headache Signals a Rare Pineal Region Brain Tumor


A Headache That Should Never Be Ignored

Most headaches experienced by young adults are benign, often resulting from tension, migraine, sleep deprivation, or viral illnesses. Consequently, persistent headaches are frequently managed conservatively before advanced imaging is considered.

However, not every headache is harmless.

When a headache is accompanied by persistent nausea, repeated vomiting, and progressive intracranial pressure symptoms, neuroimaging becomes an urgent diagnostic necessity rather than an optional examination. Brain tumors located around the pineal region may obstruct cerebrospinal fluid (CSF) circulation, rapidly leading to obstructive hydrocephalus—a neurological emergency that requires immediate recognition.

The present case illustrates precisely such a scenario.

A 31-year-old man presented with approximately 10 days of persistent headache, nausea, repeated vomiting, and photophobia. Although neurological examination was largely unremarkable, contrast-enhanced CT demonstrated a pineal region mass causing obstruction of the cerebral aqueduct with secondary obstructive hydrocephalus. Surgical resection subsequently confirmed the diagnosis of High-Grade Astrocytoma with Piloid Features (HGAP), a recently recognized and exceptionally rare central nervous system tumor.

This case highlights why radiologists must evaluate not only the presence of a tumor but also its impact on CSF dynamics, ventricular enlargement, and brainstem compression.


Why This Case Matters

High-Grade Astrocytoma with Piloid Features (HGAP) represents one of the newest entities recognized within modern CNS tumor classification.

Unlike conventional glioblastoma, HGAP possesses distinct molecular characteristics and frequently demonstrates activation of the MAPK pathway together with alterations involving CDKN2A/B, ATRX, and NF1. Because of these molecular differences, imaging findings alone rarely establish a definitive diagnosis, making multidisciplinary integration of radiology, pathology, and molecular genetics essential.

Even more challenging, HGAP may mimic several pineal region tumors, including:

  • Germinoma
  • Pineoblastoma
  • Pineocytoma
  • Pilocytic astrocytoma
  • Glioblastoma

Accurate radiologic differentiation therefore directly influences surgical planning and subsequent treatment decisions.


Clinical Presentation

The patient's symptoms developed gradually over approximately ten days and included:

  • Persistent headache
  • Progressive nausea
  • Recurrent vomiting
  • Photophobia

Although these symptoms may initially resemble migraine or viral illness, together they strongly suggest increasing intracranial pressure secondary to obstructive hydrocephalus.

Importantly, neurological examination may remain relatively normal during the early phase despite substantial ventricular enlargement. This disconnect between clinical examination and imaging findings reinforces the indispensable role of emergency neuroimaging.


Understanding the Pathophysiology

The pineal gland is situated immediately posterior to the third ventricle and superior to the cerebral aqueduct.

Because of this strategic anatomical location, even a relatively modest increase in tumor size can obstruct normal cerebrospinal fluid flow.

The sequence of pathological events is straightforward:

  1. Pineal region tumor enlarges.
  2. Compression of the cerebral aqueduct occurs.
  3. CSF circulation becomes blocked.
  4. Ventricular dilation develops.
  5. Intracranial pressure rises.
  6. Neurological deterioration follows if untreated.

In HGAP, rapid tumor growth accelerates this process, producing acute obstructive hydrocephalus that may progress toward brain herniation without timely intervention.


Epidemiology

HGAP remains an extremely uncommon neoplasm.

Current observations indicate that:

  • It primarily affects young adults.
  • The average age ranges from approximately 30 to 40 years.
  • Both males and females may be affected.
  • Pineal region involvement is particularly rare, with most published evidence consisting of isolated case reports.

Because of its rarity, many practicing radiologists may encounter only one or two cases throughout their careers.


Molecular Characteristics

One of the defining features of HGAP is its distinctive molecular profile.

Frequently reported alterations include:

  • MAPK pathway activation
  • CDKN2A/B deletion
  • ATRX mutation
  • NF1 alteration

These abnormalities distinguish HGAP from classic glioblastoma and support its recognition as a separate diagnostic entity.

As precision oncology continues to evolve, molecular profiling will increasingly guide prognosis, targeted therapy selection, and clinical trial enrollment.


CT Findings Every Radiologist Should Recognize

Emergency CT remains the first-line imaging modality for patients presenting with symptoms of raised intracranial pressure.

In this case, several critical imaging findings were identified.

Figure 1. Sagittal Contrast-Enhanced CT

The sagittal reconstruction demonstrated:

  • Enhancing pineal region mass
  • Direct compression of the cerebral aqueduct
  • Enlargement of the lateral and third ventricles

These findings explain the patient's obstructive hydrocephalus and establish the immediate cause of intracranial hypertension.


Figure 2. Axial Contrast-Enhanced CT

Axial contrast-enhanced imaging revealed:

  • Heterogeneous enhancement
  • Central necrotic component
  • Imaging features suspicious for a high-grade neoplasm

The presence of internal necrosis strongly favors an aggressive tumor rather than a benign pineal lesion.


Figure 3. Non-Contrast CT

Non-enhanced CT demonstrated:

  • Intratumoral calcification
  • Low-attenuation necrotic regions
  • Significant mass effect

Calcification is an important feature when evaluating pineal region tumors and contributes substantially to differential diagnosis.

MRI Evaluation: The Essential Next Step Beyond CT

While CT rapidly identifies obstructive hydrocephalus and life-threatening ventricular enlargement, magnetic resonance imaging (MRI) provides the anatomical and biological information necessary for definitive surgical planning.

In this case, the source material emphasizes that MRI is indispensable for evaluating:

  • Tumor margins
  • Local infiltration
  • Brainstem invasion
  • Diffusion restriction
  • Perfusion characteristics
  • MR spectroscopy findings

These advanced MRI sequences allow neuroradiologists to estimate tumor aggressiveness, define resection boundaries, and evaluate structures that may not be adequately characterized on CT.


The Radiologist's Imaging Checklist

Before issuing a diagnostic report, neuroradiologists should systematically evaluate several critical imaging features.

Tumor Characteristics

✔ Exact anatomical location

✔ Maximum tumor size

✔ Internal architecture

✔ Enhancement pattern

✔ Presence of necrosis

✔ Intratumoral calcification

Ventricular System

✔ Cerebral aqueduct obstruction

✔ Third ventricular compression

✔ Lateral ventricular enlargement

✔ Degree of hydrocephalus

Brain Compression

✔ Brainstem involvement

✔ Midline shift

✔ Mass effect

Emergency Indicators

✔ Evidence of elevated intracranial pressure

✔ Need for urgent CSF diversion

✔ Surgical urgency

This structured evaluation minimizes diagnostic oversight and facilitates communication between radiologists and neurosurgeons.


Differential Diagnosis of Pineal Region Masses

Because pineal region tumors frequently share overlapping imaging appearances, radiologists must integrate enhancement characteristics, necrosis, calcification, and patient demographics.

1. Germinoma

Typically affects young males.

Imaging Characteristics

  • Homogeneous enhancement
  • Relatively uniform internal architecture
  • Limited surrounding infiltration
  • Diffusion restriction on DWI

Compared with the present case, germinomas usually lack extensive necrosis and heterogeneous enhancement.


2. Pineoblastoma

Highly aggressive embryonal tumor.

Typical imaging findings include:

  • Large infiltrative mass
  • Frequent CSF dissemination
  • High cellularity
  • Diffusion restriction

MRI diffusion-weighted imaging plays a particularly important role in differentiation.


3. Pineocytoma

Generally considered benign.

Typical features include:

  • Well-defined margins
  • Homogeneous enhancement
  • Slowly progressive hydrocephalus
  • Minimal or absent necrosis

These findings contrast markedly with the aggressive imaging characteristics demonstrated in this patient.


4. Pilocytic Astrocytoma

Perhaps the most important differential diagnosis.

Although both tumors share piloid features histologically, pilocytic astrocytoma generally demonstrates:

  • WHO Grade 1 biology
  • Slow growth
  • Rare necrosis
  • Favorable prognosis

Conversely, HGAP behaves as a biologically aggressive neoplasm.


5. Glioblastoma

Glioblastoma remains the most common high-grade glioma in adults.

However,

  • Pineal region occurrence is uncommon.
  • Molecular characteristics differ substantially from HGAP.

Therefore, pathological and molecular confirmation remains essential.

The accompanying case material emphasizes that the combination of heterogeneous enhancement, necrosis, aqueductal compression, and obstructive hydrocephalus should prompt consideration of HGAP within the differential diagnosis.


AI-Powered Radiology Workflow

Modern neuroradiology increasingly integrates artificial intelligence to improve diagnostic accuracy and workflow efficiency. While the attached case focuses on imaging interpretation rather than AI implementation, its structured assessment naturally aligns with AI-assisted analysis.

An AI-enhanced workflow may include:

Step 1. Emergency CT Detection

AI algorithms automatically identify:

  • Pineal region masses
  • Ventricular enlargement
  • Midline shift
  • Obstructive hydrocephalus

Immediate alerts can shorten the time from image acquisition to neurosurgical consultation.

Step 2. Automated Tumor Segmentation

Deep-learning segmentation tools can calculate:

  • Tumor volume
  • Necrotic fraction
  • Compression of adjacent structures
  • Three-dimensional surgical maps

Step 3. Quantitative MRI Analysis

Radiomics and advanced MRI analytics may evaluate:

  • Diffusion heterogeneity
  • Perfusion biomarkers
  • Texture signatures
  • Spectroscopic abnormalities

These quantitative biomarkers may support noninvasive prediction of tumor grade.

Step 4. Clinical Decision Support

AI systems can integrate:

  • Imaging findings
  • Molecular profiles
  • Pathology
  • Clinical symptoms

to generate differential diagnoses and assist multidisciplinary tumor board discussions.

Importantly, AI is intended to augment—not replace—the expertise of neuroradiologists and neurosurgeons.


Treatment Strategy

According to the attached case review, treatment follows several sequential priorities.

1. Emergency Management

Patients presenting with obstructive hydrocephalus require immediate reduction of intracranial pressure.

Initial interventions may include:

  • Cerebrospinal fluid drainage
  • External Ventricular Drain (EVD)
  • Endoscopic Third Ventriculostomy (ETV)

Failure to relieve CSF obstruction may result in rapid neurological deterioration.


2. Surgical Resection

Maximum safe tumor removal remains the cornerstone of management.

Primary surgical objectives include:

  • Histopathological diagnosis
  • Relief of mass effect
  • Restoration of CSF circulation
  • Improvement of long-term survival

In the presented case, surgical resection established the definitive diagnosis of High-Grade Astrocytoma with Piloid Features.


3. Postoperative Radiotherapy

The source document notes that postoperative radiotherapy is an important component of treatment for high-grade gliomas.


4. Chemotherapy

Temozolomide-based therapy may be considered; however, the document also notes that HGAP differs molecularly from conventional glioblastoma, and targeted therapeutic strategies remain an active area of research.

Prognosis and Long-Term Outcomes

High-Grade Astrocytoma with Piloid Features (HGAP) is recognized as a distinct central nervous system tumor with biological behavior that falls between conventional pilocytic astrocytoma and glioblastoma. Although its histologic appearance may resemble low-grade piloid tumors, its clinical course is generally more aggressive, particularly when complete surgical resection cannot be achieved.

The prognosis depends on multiple clinical, radiological, molecular, and therapeutic factors.

Major Prognostic Factors

Extent of Surgical Resection

Among all prognostic variables, the extent of tumor removal remains one of the strongest predictors of outcome.

Patients undergoing gross total resection generally experience:

  • Longer progression-free survival
  • Lower recurrence rates
  • Reduced residual tumor burden
  • Improved neurological recovery

However, pineal region tumors frequently involve deep midline structures adjacent to the:

  • Midbrain
  • Tectal plate
  • Internal cerebral veins
  • Vein of Galen
  • Deep venous complex

Consequently, complete resection may be technically impossible without unacceptable neurological morbidity.


Molecular Profile

Modern WHO CNS tumor classification increasingly emphasizes molecular diagnostics.

Important biomarkers include:

  • CDKN2A/B deletion
  • MAPK pathway alterations
  • ATRX expression
  • TERT promoter mutation
  • MGMT promoter methylation
  • BRAF alterations (occasionally identified)

These biomarkers not only improve diagnostic accuracy but may eventually guide individualized treatment strategies as targeted therapies continue to evolve.


Hydrocephalus at Presentation

Patients presenting with severe obstructive hydrocephalus often require urgent cerebrospinal fluid diversion before definitive tumor treatment.

Fortunately, hydrocephalus itself does not necessarily predict poor oncologic outcomes if:

  • Intracranial pressure is rapidly controlled.
  • Definitive tumor treatment proceeds without significant delay.
  • Neurological deterioration is prevented.

Prompt recognition by radiologists therefore has direct implications for patient survival.


Histologic Grade

Although HGAP demonstrates piloid differentiation microscopically, several aggressive histologic features correlate with worse prognosis:

  • High mitotic activity
  • Microvascular proliferation
  • Tumor necrosis
  • Elevated proliferative index (Ki-67)
  • Increased cellular atypia

These findings explain why HGAP behaves more aggressively than conventional pilocytic astrocytoma.


Imaging Follow-Up

Postoperative imaging plays a pivotal role in monitoring treatment response and detecting recurrence.

Immediate Postoperative MRI

Typically performed within 24–72 hours, MRI is used to assess:

  • Residual enhancing tumor
  • Surgical complications
  • Hemorrhage
  • Infarction
  • Ventricular decompression
  • Resolution of hydrocephalus

Early imaging provides the baseline for all future surveillance studies.


Surveillance MRI

Follow-up MRI generally evaluates:

  • Tumor recurrence
  • New enhancement
  • Progressive mass effect
  • Ventricular size
  • Radiation-induced changes
  • Treatment-related necrosis

Advanced MRI techniques—including perfusion imaging, diffusion-weighted imaging, and MR spectroscopy—may help distinguish recurrent tumor from post-treatment effects.


Radiology Pearls

This case illustrates several important teaching points for practicing radiologists.

Pearl 1

Hydrocephalus is often the first life-threatening manifestation rather than the tumor itself.

When enlarged lateral ventricles accompany a pineal mass, immediate evaluation of the cerebral aqueduct is essential.


Pearl 2

Never underestimate a pineal lesion based solely on size.

Relatively small tumors may produce profound obstructive hydrocephalus because of the confined anatomy surrounding the aqueduct of Sylvius.


Pearl 3

CT identifies the emergency.

MRI defines the disease.

Emergency CT rapidly establishes the presence of:

  • Ventricular enlargement
  • Mass effect
  • Hydrocephalus

MRI subsequently provides the detailed tissue characterization required for definitive diagnosis and operative planning.


Pearl 4

Enhancement heterogeneity matters.

A heterogeneous enhancing pineal tumor containing necrosis should immediately raise suspicion for a high-grade neoplasm.


Pearl 5

Diffusion imaging provides valuable biological information.

Marked diffusion restriction often reflects:

  • High cellularity
  • Increased tumor aggressiveness
  • Embryonal tumors
  • High-grade gliomas

DWI therefore contributes significantly to differential diagnosis.


Pearl 6

Always evaluate the entire neuraxis.

Aggressive pineal tumors may disseminate through cerebrospinal fluid pathways.

Spinal MRI should be considered when dissemination is suspected.


Practical Reporting Template

An organized radiology report improves communication with neurosurgeons and oncologists.

Examination

MRI Brain with and without intravenous contrast


Findings

Location: Pineal region.

Tumor Dimensions: Provide measurements in three orthogonal planes.

Morphology:

  • Heterogeneous enhancing mass
  • Central necrosis
  • Internal hemorrhage (if present)
  • Calcification (if present)

Relationship to Adjacent Structures:

  • Compression of the cerebral aqueduct
  • Third ventricular displacement
  • Brainstem compression
  • Involvement of deep venous structures

Hydrocephalus:

  • Enlargement of lateral ventricles
  • Enlargement of third ventricle
  • Transependymal CSF flow (if present)

Advanced MRI Findings:

  • Diffusion restriction
  • Perfusion characteristics
  • Spectroscopy abnormalities

Impression

  • Pineal region high-grade neoplasm causing obstructive hydrocephalus.
  • Imaging features favor High-Grade Astrocytoma with Piloid Features (HGAP), although pineoblastoma and germinoma remain differential considerations.
  • Findings warrant urgent neurosurgical consultation.
  • Recommend histopathologic and molecular confirmation following surgical resection.

MediAI Clinical Insight

How AI Can Improve This Case

The future of neuroradiology lies not in replacing radiologists but in enhancing their diagnostic capabilities through intelligent assistance.

An integrated MediAI platform could automatically:

  • Detect pineal region masses on emergency CT.
  • Quantify ventricular enlargement.
  • Measure Evans Index and ventricular volumes.
  • Segment tumors in three dimensions.
  • Detect aqueductal obstruction.
  • Estimate tumor grade using radiomic biomarkers.
  • Generate structured radiology reports.
  • Prioritize emergency cases within the PACS worklist.
  • Compare current studies with prior examinations.
  • Integrate imaging with pathology, genomic profiling, and clinical data through interoperable standards such as DICOM and HL7/FHIR.

Such AI-assisted workflows have the potential to reduce diagnostic delays, improve consistency, and support multidisciplinary decision-making while preserving the central role of expert neuroradiologists.


Frequently Asked Questions (FAQ)

Q1. Why is hydrocephalus the primary emergency in pineal tumors?

Because the pineal gland lies immediately adjacent to the cerebral aqueduct, even modest tumor enlargement can obstruct cerebrospinal fluid flow, producing rapidly increasing intracranial pressure.


Q2. Can CT alone diagnose HGAP?

No. CT is excellent for detecting hydrocephalus, hemorrhage, and mass effect but lacks the tissue characterization necessary for definitive diagnosis. MRI with advanced sequences is essential, and histopathological plus molecular confirmation remains the diagnostic gold standard.


Q3. Why is MRI diffusion imaging important?

Diffusion-weighted imaging reflects tissue cellularity. Highly cellular tumors often demonstrate restricted diffusion, aiding differentiation between tumor types and helping estimate biological aggressiveness.


Q4. Is pineal HGAP common?

No. HGAP itself is uncommon, and occurrence within the pineal region is exceptionally rare, making awareness of its imaging features particularly important for accurate diagnosis.


Q5. Can artificial intelligence replace neuroradiologists?

No. AI is best viewed as a decision-support technology that enhances detection, quantification, workflow prioritization, and structured reporting. Final interpretation, clinical integration, and management decisions remain the responsibility of experienced radiologists and multidisciplinary teams.


Key Takeaways

  • HGAP is a recently recognized, biologically aggressive CNS tumor that may rarely arise in the pineal region.
  • Obstructive hydrocephalus is frequently the initial life-threatening presentation and requires urgent recognition.
  • CT rapidly detects ventricular enlargement and mass effect, whereas MRI defines tumor extent, tissue characteristics, and surgical anatomy.
  • Differential diagnosis includes germinoma, pineoblastoma, pineocytoma, pilocytic astrocytoma, and glioblastoma.
  • Advanced MRI techniques—including diffusion-weighted imaging, perfusion imaging, and MR spectroscopy—provide valuable biological insights.
  • Surgical resection with histopathologic and molecular evaluation remains essential for definitive diagnosis.
  • AI-assisted neuroradiology can improve emergency detection, quantitative assessment, structured reporting, and multidisciplinary workflow without replacing physician expertise.

Conclusion

High-Grade Astrocytoma with Piloid Features (HGAP) of the pineal region represents a rare but clinically significant diagnostic challenge. Its deep-seated location, propensity to obstruct cerebrospinal fluid pathways, and overlapping imaging characteristics with other pineal tumors demand a systematic and multimodal diagnostic approach.

Emergency CT serves as the frontline modality by rapidly identifying obstructive hydrocephalus and life-threatening ventricular enlargement, enabling timely neurosurgical intervention. MRI then provides comprehensive anatomical and biological characterization through advanced sequences, guiding surgical planning and refining the differential diagnosis. Definitive diagnosis ultimately relies on histopathological examination supplemented by molecular profiling, reflecting the modern WHO framework for central nervous system tumors.

As neuroradiology continues to evolve, artificial intelligence offers powerful opportunities to augment clinical practice by enhancing emergency detection, automating quantitative analysis, generating structured reports, and integrating imaging with pathology and genomic data. Nevertheless, optimal patient care will continue to depend on the collaborative expertise of neuroradiologists, neurosurgeons, neuropathologists, and neuro-oncology teams.

This case highlights the critical importance of recognizing obstructive hydrocephalus as a neurological emergency, applying advanced MRI for comprehensive lesion characterization, and leveraging emerging AI technologies to support precision neuro-oncology. By combining meticulous imaging interpretation with multidisciplinary management, clinicians can improve diagnostic confidence, expedite life-saving interventions, and ultimately enhance outcomes for patients with these exceptionally rare and aggressive tumors.


References

  1. D. N. Louis et al., “The 2021 WHO Classification of Tumors of the Central Nervous System: a summary,” Neuro-Oncology, vol. 23, no. 8, pp. 1231–1251, 2021.
  2. WHO Classification of Tumours Editorial Board, Central Nervous System Tumours, 5th ed., Lyon, France: International Agency for Research on Cancer, 2021.
  3. C. G. Hawkins et al., “High-grade astrocytoma with piloid features: integrated diagnostic and molecular characterization,” Acta Neuropathologica, 2021.
  4. D. T. W. Jones and S. M. Pfister, “The evolving molecular landscape of glioma,” Nature Reviews Cancer, vol. 23, pp. 289–305, 2023.
  5. M. Weller et al., “EANO guidelines on the diagnosis and treatment of diffuse gliomas,” The Lancet Oncology, vol. 22, no. 8, 2021.
  6. P. C. Burger and B. W. Scheithauer, Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Pathology.
  7. R. Jain, A. Ellika, and A. Scarpace, “Advanced MR imaging in brain tumors,” Radiologic Clinics of North America, vol. 49, no. 1, pp. 45–61.
  8. S. Bakas et al., “Advancing the cancer genome atlas glioma MRI collections with expert segmentation labels and radiomic features,” Scientific Data, vol. 4, 2017.
  9. E. B. Claus et al., “Survival and low-grade glioma: the emergence of molecular classification,” Journal of Clinical Oncology, vol. 33, no. 15.
  10. A. Kickingereder et al., “Radiomic profiling of glioblastoma: identifying imaging biomarkers for precision oncology,” European Radiology, vol. 26, pp. 4681–4688.

Comments

Popular posts from this blog

Understanding Tubal Ligation Clips: Imaging, Risks, Migration, and Management

Teres Minor Atrophy: Causes, Imaging, and Clinical Implications

The Lethal Lens: Mastering the Diagnosis and Management of Epidural Hemorrhage (EDH)